Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen (MAGENTA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03081910 |
|
Recruitment Status :
Recruiting
First Posted : March 16, 2017
Last Update Posted : February 12, 2024
|
Sponsor:
Baylor College of Medicine
Collaborators:
Center for Cell and Gene Therapy, Baylor College of Medicine
The Methodist Hospital Research Institute
Information provided by (Responsible Party):
Rayne Rouce, Baylor College of Medicine
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 15, 2025 |
| Estimated Study Completion Date : | September 1, 2040 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):